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sults of using the various estimation methods will be pre-
sented and discussed at the meeting.
CONCLUSIONS: Survival data from clinical trials are
normally not analyzed with the purpose of determining
average survival, but such estimates are necessary for
economic evaluation. Due to censoring, mean survival
can not be estimated without extrapolation or without
truncation in a restricted means analysis. The results in
terms of ICER will vary according to the estimation
method used. These variations should be examined in
sensitivity analyses
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OBJECTIVE: QuOLA-T was established as a real-life UK
outcomes audit to measure changes in Quality of Life (us-
ing the EORTC QLQ-C30 questionnaire) in patients with
metastatic breast cancer treated with docetaxel (Taxo-
tere®) outside the parameters of formal clinical trials.
METHODS: QuOLA-T is an ongoing programme in
which Quality of Life (QoL), clinical parameters of perfor-
mance status (Karnofsky Index) and response data are col-
lected at baseline and after every two cycles of treatment
and following chemotherapy. Demographic parameters
are also collected at baseline. Evaluable patients were de-
fined as those for whom a baseline registration and QoL
form have been received, details of chemotherapy are com-
pleted and at least one QoL form from the treatment phase
has been received. Non-evaluable patients were those still
receiving treatment and those not meeting the criteria
above. There were no significant differences between eval-
uable and non-evaluable patients in any of the parameters
at baseline, indicating that evaluable patients are a fair
representation of the entire data set.
RESULTS: The median number of cycles of Taxotere ad-
ministered: 5 (range 1–9). 103 patients completed planned
chemotherapy (49%), with a median of 6 cycles. Major
reason for withdrawal from treatment was progressive dis-
ease (25%), median number of cycles: 4. There were sig-
nificant detrimental intra-patient changes in two of the
QLQ-C30 domains (Fatigue and Diarrhea) but there were
significant beneficial intra-patient changes in four of the
domains (Emotional Functioning, Pain, Constipation and
Nausea and Vomiting).
CONCLUSIONS: This is the first large prospective Qual-
ity of Life monitoring programme conducted in an unse-
lected population of patients with metastatic breast cancer
using a recognized instrument. The hypothesis that quality
of life is significantly decreased during the active phase of
chemotherapy with Taxotere is not supported. This study
provides a much clearer picture of the real-life effects of
Taxotere on Quality of Life.
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OBJECTIVE: To investigate the effect of adjuvant breast
cancer therapy on quality of life, and to evaluate the oc-
currence of dose delay or reduction by type of therapy.
MATERIALS AND METHODS: The study population
was drawn from patients treated by a major oncology cen-
ter in Southern California. The inclusion criteria were: fe-
males 18 years old or older treated with adjuvant therapy,
with stage I, II or III non-metastatic breast cancer. Partici-
pants were sent up to five surveys: one before treatment ini-
tiation, two or three (depending on the number of cycles) at
regular intervals between treatments, and a final one 4
weeks after the end of the chemotherapy session. The survey
contained two quality of life instruments: the SF-36 and the
Breast Cancer Chemotherapy Questionnaire (BCQ).
RESULTS: At the beginning of the chemotherapy course,
40 patients were prescribed CMF (48.2%), 24 AC
(28.9%), 11 A-CMF sequential (13.3%), and 8 other regi-
mens (9.6%). Average values for the physical component
summary score (PCS) of the SF-36 did not vary over time,
ranging from 42.1 to 46.1. The mental component sum-
mary score (MCS) had a peak at mid-point (48.1), while it
stabilized to the initial value at the end of the therapy
(46.8 vs. 46.5). Comparisons of the difference between the
baseline quality of life scores and a summary measure of
the subsequent scores among treatment groups were not
significant. Correlation coefficients showed that, at each
period, MCS score was highly correlated with the disease-
specific BCQ score (correlation coefficients from 0.69 to
0.81, p  0.001). During the chemotherapy course, 32 pa-
tients experienced a dose delay, 12 a dose reduction and 9
prematurely terminated their chemotherapy regimen, with
no difference among treatment groups.
DISCUSSION: The MCS of the SF-36 was highly correlated
with the disease specific instrument, while the PCS was not.
QUALITY OF LIFE STUDY RESULTS
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OBJECTIVES: To evaluate the quality of life (QL) in es-
sential hypertensives (EH) of Belarus, a European country
with a unique combination of the important rise in cardio-
vascular morbidity and mortality, highly restricted financ-
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ing of the state health care system, and the society experi-
encing socioeconomic hardships.
METHODS: In 222 verified mild to moderate EH (mean
age 49.4  0.9 years) as well as in 77 age-, gender-, body
mass- and social status-matched healthies (H) the QL as-
sessment was performed using the well-validated, self-
administered questionnaires: The Giessen Somatic Com-
plaints Questionnaire (GSC) and The General Well-Being
Adjustment Scale (GWB).
RESULTS: The QL tests revealed significantly lower QL
scores on all GSC and GWB subscales in the investigated
Belarusian EH compared with H (Gastric Complaints,
Pains, Cardiac Complaints, Exhaustion, Anxiety, Depres-
sion, Well-Being, Self-Control, General Health, Vitality)
with the total Complaints Index (mean  SEM) 52.4  2.6
vs. 22.5  1.9 points (p  0.001), and the total GWB in-
dex 78.6  1.3 vs. 94.5  2.1 points (p  0.01), respec-
tively. QL scores did not correlate (Spearman) with office
blood pressure and age. Females demonstrated less favor-
able scores on all subscales compared with males in both
groups (Mann-Whitney, p  0.01). Educational level, oc-
cupation, physical activity had no impact on the QL
(ANOVA). There was an association of the total QL with
alcohol and coffee consumption as well as smoking (stan-
dardized interview), while abstinents had the lowest QL
scores (p  0.05). The QL total indexes were significantly
(p  0.05) worse in the EH treated on regular basis com-
pared with EH who did not treat their known hyperten-
sion. The high QL score, smoking, drinking and male gen-
der were revealed as factors of poor compliance with
previous routine medical care.
CONCLUSIONS: Gender and certain life-style factors in-
fluence the QL profile of EH living in Belarus and relate to
compliance, this requiring careful consideration during hy-
pertension management.
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OBJECTIVES: A rigorous translation methodology is es-
sential in order to develop equivalent language versions of
health-related quality of life questionnaires for use in clini-
cal research and trials. Using differential item functioning
(DIF) within the item response theory framework to aug-
ment traditional reliability analysis provides additional evi-
dence to evaluate whether the translated versions are psy-
chometrically equivalent.
METHODS: The Functional Assessment of Chronic Illness
Therapy (FACIT) Measurement System translation meth-
odology consists of 2 forward translations, 1 reconciled
version, a back-translation of the reconciled version, and 3
independent reviews by bilingual experts. The translated
versions are then pretested with at least 15 patients in the
respective native countries. In this presentation, we focus
on five translated versions of the FACT-G (Hungarian, Jap-
anese, Polish, Portuguese, and Russian) that were each
tested with at least 40 patients and analyzed; the total sam-
ple was 316 oncology patients. The internal consistency of
the 27-item core FACT-G was evaluated using Cronbach’s
alpha. Rasch analysis was used to determine the item diffi-
culty hierarchy of each language version, and then DIF
analysis was used to determine psychometric equivalence in
relation to the English version (n  131).
RESULTS: The 27 core FACT-G items included in every
FACIT measure showed high reliability in these five lan-
guage versions, with Cronbach’s alpha ranging from .87
(Japanese) to .93 (Polish). Items exhibiting potential DIF
and their possible causes were summarized.
CONCLUSION: Reliability and DIF analyses confirm that
the five translated versions are psychometrically valid and
comparable. The FACIT translation methodology has been
effective in adapting a North American questionnaire to
vastly different cultural contexts and creating valid versions
for cross-cultural comparisons. Further research and devel-
opment of new language versions is needed, especially in
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OBJECTIVES: The use of antipsychotics in the treatment
of schizophrenia has changed patient connections to their
surroundings, placing them in greater contact with their
family and the environment in which they carry out daily
activities. The purpose of this analysis of patients in the
naturalistic setting was to evaluate the changes in health
related quality of life (HRQL) associated with antipsy-
chotic drug therapy and to evaluate the sensitivity of the
Euroqol-5D (EQ-5D) as a tool for measuring HRQL in
patients with schizophrenia.
METHODS: The study included 2,128 patients with
schizophrenia who were treated with olanzapine, 821 who
were treated with risperidone or haloperidol, and small
numbers of patients on other antipsychotics. Sociodemo-
graphic, clinical (global clinical impression, global activity
evaluation scale, presence of extrapyramidal symptoms)
and the EQ-5D as a generic tool for the measurement of
the HRQL were included as variables. The patients were
evaluated at treatment initiation and after 6 months.
RESULTS: Olanzapine-treated patients showed the larg-
est effect size on the Visual Analog Scale (VAS) (0.98)
